HSDD refers to a lack of sexual desire that causes distress and/or trouble with personal relationships. It’s normal for women to lose interest in sex from time to time, but for women with HSDD, the problem is persistent. Acquired HSDD occurs after a woman has had a healthy sex drive for some period of time, often many years. Generalized HSDD happens with any sexual partner and any sexual situation.
Addyi works by balancing chemicals the brain that influence sexual desire. (Learn more here.)
The drug was approved by the U.S. Food and Drug Administration (FDA) in August 2015. It is expected to be available in the United States by October 17, 2015.